| Description |
1 online resource |
| Series |
Updates in clinical dermatology |
|
Updates in clinical dermatology.
|
| Contents |
Intro -- Preface -- Contents -- Contributors -- 1: Introduction to Clinical Rosacea -- Rosacea Is a Syndrome and Not a Pathogenically Defined Disease -- History of Classification of Rosacea: Distinction from Acne and Recognition of Phenotypic Subtypes -- The Four Classic Phenotypic Subtypes of Rosacea Have Important Utilities -- The Flawed Proposal to Eliminate the Classic Phenotypic Subtypes -- The Classic Phenotypic Subtypes Are Useful and Will Persist -- Incidence -- History -- History of Present Illness -- Past Medical History -- Medication History -- Family History -- Social History |
|
Review of Systems -- Physical Exam -- Differential Diagnoses -- Histology -- References -- 2: Pathophysiology of Rosacea -- Introduction -- Current Concepts of the Pathophysiology -- Genes in Rosacea -- Innate Immunity and Adaptive Immunity -- Neuroimmune and Neurovascular Dysregulation -- Novel Insights and Promising Targets -- Future Studies -- Conclusion -- References -- 3: Genetics of Rosacea -- Background -- Epidemiology -- Familial Inheritance Studies -- Twin Concordance Studies -- Gene Association Case-Control Studies -- Molecular and Functional Data -- Endoplasmic Reticulum (ER) Stress |
|
Toll-Like Receptor (TLR)-2 -- Antimicrobial Peptides -- Transient Receptor Potential Vanilloid 1 (TRPV1) -- Neurovascular Factors -- Mast Cells -- IL-17 -- TSLP -- Associations with Comorbidities -- Conclusion and Future Directions -- References -- 4: Evidence-Based Management -- Introduction -- Environmental Modification -- Topical Therapies -- Metronidazole -- Azelaic Acid -- Sodium Sulfacetamide-Sulfur -- Calcineurin Inhibitors -- Crotamiton, Ivermectin, and Permethrin -- Clindamycin -- Retinoids -- Systemic Therapies -- Doxycycline and Minocycline -- Macrolides -- Antihypertensives |
|
Isotretinoin -- Conclusion -- References -- 5: Difference in Vasoconstrictors: Oxymetazoline Versus Brimonidine -- Introduction -- Vascular Anatomy -- Brimonidine -- Pharmacodynamics and Pharmacokinetics -- Administration and Interactions -- Indication and Clinical Management -- Efficacy -- Adverse Effects -- Oxymetazoline -- Pharmacodynamics and Pharmacokinetics -- Administration and Interactions -- Indication and Clinical Management -- Efficacy -- Adverse Effects -- Oxymetazoline Versus Brimonidine -- Conclusion -- References -- 6: Treatment of Ocular Rosacea -- Introduction |
|
Conservative Therapy -- Topical Medical Therapy -- Systemic Therapy -- Procedural and Surgical Therapy -- Future Directions -- Conclusion -- References -- 7: Physical Modalities for the Treatment of Rosacea -- Introduction -- Light and Laser Applications for Vascular Lesions -- Pulsed Dye Laser (PDL) -- KTP Laser -- Long-Pulsed Nd:YAG Laser -- Intense Pulse Light (IPL) -- Summary: Therapy of Vascular Lesions -- Physical Therapeutic Options in the Treatment of Phymatous Rosacea Manifestations -- Dermashaving (Scalpel) -- Dermabrasion -- Electrosurgery (Fig. 7.1a-c) -- Laser Surgery (Fig. 7.2a, b) |
| Summary |
Of Therapeutic Options in Phymatous Lesions of Rosacea |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from digital title page (viewed on November 02, 2020) |
| Subject |
Rosacea.
|
|
Rosacea
|
| Genre/Form |
Electronic books
|
| Form |
Electronic book
|
| Author |
Cary, John Havens, editor
|
|
Maibach, Howard I., editor
|
| ISBN |
3030520978 |
|
9783030520977 |
|
